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Abstract
Background: It is evident that professional driving is associated with substantial changes in lifestyle habits. Professional
drivers are prone to metabolic syndrome (MetS) and its complications because their working environment is characterized
by numerous stress factors such as lack of physical activity due to working in a fixed position, disruption in diet, and
irregular sleep habits. The aim of the present study was to estimate the prevalence of MetS among long distance drivers
residing in West Azerbaijan province in Iran.
Materials: To assess the prevalence of metabolic syndrome among professional long distance drivers, 12138 participants
were enrolled in this cross sectional study. The MetS was defined using International Diabetes Federation criteria.
Results: Among12138 participants, 3697 subjects found to be MetS. The crude and age-adjusted rates of MetS were 30.5%
and 32.4% respectively. Based on Body mass index (BMI), 5027 subjects (41.4%) were overweight (BMI $25.01–30 kg/m2),
and 2592 (21.3%) were obese (BMI $30.01 kg/m2). The presence of central obesity was more common than other
components. The associations of MetS with BMI, pack-year smoking, age, weekly driving duration and driving experiences
were significant in the logistic regression. By increasing BMI, pack-year smoking, age, weekly driving duration and driving
experiences, odds ratio of MetS was increased.
Conclusion: The study suggests that MetS has become a noteworthy health problem among Iranian long distance drivers.
This might be due to the following facts: sitting in a fixed position for long hours while working, cigarette smoking, job
stress, unhealthy diet and lack of physical activity. Educational programs should be established for promoting healthy
lifestyle and also for early detection and appropriate interventions
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Introduction
A global transition in the disease pattern has been observed,
where the relative impact of infectious diseases is decreasing while
chronic diseases like cardiovascular disease (CVD) and diabetes
are increasingly dominating the disease pattern [1]. In the United
States, age-adjusted MetS prevalence among adults population
was estimated to be 24–25%. Similarly, the prevalence of MetS in
7 European countries was approximately 23%. It was estimated
that 20%–25% of South Asians have developed MetS [2,3]. In
Iran, a high prevalence of this disorder has been documented
among general population. According to a nationwide study, the
age-standardized prevalence of the metabolic syndrome in Iranian
men population was about 28.8% based on the Adult Treatment
Panel-III (ATP III) criteria, and 27.5% (95% CI 25.7–29.3) based
on the International Diabetes Federation (IDF) definition [4]. In
the Tehran study, the age-standardized prevalence of this
syndrome in 4397 Iranian men population was estimated 24%
and 21% based on the ATP III and the IDF definitions
respectively [5,6]. In Zanjan province in Iran, where the main
ethnic groups are Azeries (Turks) and Kurds, the prevalence of this
syndrome in men is reported to be 23.1%, based on ATP III
criteria [7]. Individuals with MetS have a higher probability of
developing diabetes and/or CVD, depending on the number of
components present [8–12]. It has also been shown that the
prevalence of the MetS become more frequent as obesity increases
[13,14]. Central obesity, one of the components of MetS, predicts
the occurrence of diabetes and overall cardiovascular risk [9]. It is
essential to initiate early detection of these chronic diseases in high
risk population groups, so that preventative action can minimize
the consequences. In this context, the aim of this study was to
estimate the prevalence among Iranian long distance drivers,
because they have unusual life styles and their working
environment is characterized by numerous stress factors such as
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disruption in diet, and irregular sleep habits [15,16].
Results
A total of 12138 male long distance drivers participated in the
study. The mean age of the subjects was 37.8 (SD=10.1) years,
ranging from 20 to 67. Considering smoking habits, 8289 (68.3%)
of participants were current smokers, 3516 (29.0%) non-smoker,
and 333(2.7%) were ex-smokers. The crude and age-standardized
prevalence of the MetS were 30.5% and 32.4%. A linear
association was observed between age group and prevalence of
MetS (Test for trend P-Value ,0.001).General characteristics of
MetS versus non MetS study subjects are presented in Table 1.
The prevalence of individual components of MetS based on age
group is reported in Table 2. The central obesity was more
common than the other components of MetS (table 2). The
number of components of MetS cases (with at least 3 components)
increased by increasing age groups (Table 3), and the difference
was statistically significant (P Value,0.001). There was a direct
association with the BMI and prevalence of MetS (table 4), and the
association was statistically significant (P,0.001). Association of
MetS with some risk factors was examined by logistic regression.
Binary logistic regression was used to examine the relationship
between MetS and BMI, smoking, age, weekly driving duration
and driving experiences. Based on Hosmer and Lemeshow’s
goodness of fit test, the model has adequate fit. According to the
smoking history participants were divided into 4 groups of non-
smokers, 10 pack-years or less, 10.1 to 20 pack-years and more
than 20 pack-years smoking. Based on driving experiences they
were divided into 3 groups of 10 years or less, 11–20 years and
more than 20 years. Mean of weekly driving duration at last year
were divided into 3 groups of less than 45 hours, 45 to less than
60 hours and 60 hours or more. BMI categories were divided
into 3 groups of 25 or less, 25.1 to less than 30 and 30 or more.
Age categories were defined as drivers aged lower than 35, drivers
aged 35–49, and drivers aged 50 or more. The results of logistic
regression are presented in Table 5. As shown in Table 5, the
associations of MetS with BMI, pack-year smoking, age, weekly
driving duration in fixed sitting position and history of driving
experiences were significant in the logistic regression. BMI and
smoking were the variables most significantly associated with the
occurrence of MetS. In over weight drivers (BMI=25.01–30 kg/
m
2) odds ratio of MetS was 6.8 (95% CI; 6.0 to 7.7) compared
with their colleagues with normal weight; and also it was 9.4
(95% CI; 8.48 to 10.5) for obese drivers (BMI=More than
30 kg/m
2). Odds ratio of MetS was 1.2(95% CI; 1.09 to 1.3) for
smoking 10 pack-years or less, 2.1(95% CI; 1.8 to 2.5) for
smoking 10.1–20 pack-years and 3.5(95% CI; 2.8 to 4.4) in those
with smoking more than 20 pack-years in comparison with non-
smoker subjects.
Discussion
The results of the present study demonstrate a noteworthy
high prevalence of MetS in drivers. This prevalence is higher
than the same age, and sex group in the general population. In a
national study, the age-standardized prevalence of the MetS in
Iranian men population was about 28.8% based on the ATP III
criteria, and 27.5% based on the IDF definition [4]. In the
Tehran study, the age-standardized prevalence of this syndrome
in 4397 Iranian men population was estimated 24% and 21%
based on the ATP III and the IDF definitions respectively [6].
Accordingly, based on ATP III criteria, the prevalence of this
syndrome was more than IDF definition in the Iranian
population. The above studies overestimate the prevalence of
M e t Sb a s e do nA T PI I Ic r i t e r i ai nt h eI r a n i a np o p u l a t i o n .I t
should be noted that the main ethnic groups of our study are the
same as those of Zanjan study [7]. In comparison with the
Zanjan study, our finding revealed that the rate of MetS was at
least 9% more than the general population. Therefore, it seems
that the excess prevalence in our survey could be attributed to
occupation and life style of our study sample.
A few studies have investigated MetS or its related components
in professional long distance drivers. In a cross sectional study,
among 429 bus and truck drivers in the central part of Iran, 35.9%
of the participants suffered metabolic syndrome based on ATP III
criteria [17]. An investigation among bus drivers in Taipei showed
that the rates of risk factors for ischemic heart disease among the
drivers were significantly higher than comparable groups of skilled
workers [18]. In a comparative study done in Norway on
cardiovascular risk factors among bus drivers and industrial
workers, it was found that bus drivers had higher mean values of
serum cholesterol, serum triglycerides, systolic, and diastolic blood
pressure [19].
Researchers looked at heart disease in bus drivers from the
1950s. Morris et al. found that rates of coronary heart disease in
bus conductors were lower than in less occupationally active bus
drivers. This seminal U.K investigation was undertaken using data
from two cohorts of British workers [20]. MetS increases the risk
for cardiovascular events [21]. On applying modified IDF, we
found that the majority of the subjects had at least one abnormal
risk factor for MetS. Each component of MetS is a known risk
factor for the development of diabetes and CAD. People with
MetS are 3–10 times more likely to develop CVD equal with a
high risk of morbidity and mortality [2,22]. Therefore, the excess
prevalence of MetS in long distance drivers is a public health
concern.
The reasons for excess risk of MetS in professional drivers
need to be studied. Some probable explanations are as follows.
Many drivers work longer than 45 hours per week. They also
work complicated shift systems due to irregular working hours,
which lead to inadequate opportunities for recovery and
unwinding. [16]. Unhealthy diet and physical inactivity are
Table 1. Basic characteristics of MetS versus non MetS
subjects.
Characteristic MetS P value
Present
Mean(±SD)
Absent
Mean(±SD)
Age (years) 41.3(10.1) 36.2(9.7) P,0.001
Weekly driving duration(hours) 51.9(20.1) 49.5(20.9) P,0.001
Driving experiences (years) 14.0(8.9) 10.2(8.0) P,0.001
Smoking (pack-years) 3.2(8.7) 2.6(7.0) P,0.001
Waist circumference (centimeter) 102.7(8.0) 88.8(10.8) P,0.001
Systolic blood pressure (mm Hg) 132.2(15.4) 121.4(12.8) P,0.001
Diastolic blood pressure (mm Hg) 83.7(10.3) 75.7(9.5) P,0.001
FBG (mg/dl) 98.8(26.8) 88.2(15.5) P,0.001
TG (mg/dl) 249.3(134.0) 142.8(95.4) P,0.001
HDL-C (mg/dl) 40.4(9.0) 45.8(9.3) P,0.001
BMI(kg/m2) 29.7(3.5) 25.3(3.7) P,0.001
doi:10.1371/journal.pone.0031790.t001
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meal consumption is related to hyperinsulinaemia, postprandial
hyperglycaemia, and hypertriglycemia that are well known to
predict an increase of body fat in working individuals [23,24]. In
Iran, most of inter-city restaurants use high saturated fat for
daily cooking. The common meals served in these restaurants
are poor in fiber, rich in animal proteins (beef, sheep, veal), and
are high in glycemic index (rice, white bread). As shown in
table 4, the increase in the BMI was accompanied by a parallel
increase in the prevalence of MetS. This may indicate the role of
unhealthy diet and physical inactivity in developing MetS in
long distance drivers.
Working environment of drivers may also play a role in
developing MetS. There are reports indicating that despite regular
exercise and a proper diet, subjects under prolonged stress
developed metabolic alterations including distinctive central
obesity, biochemical changes and a slight hypertension towards
the MetS [25]. There is a dose-response relation between exposure
to work stressors and risk of the metabolic syndrome, independent
of other relevant risk factors [26]. It has been demonstrated that
the length of work hours has been a significant factor for both
waist circumference and BMI increases in professional drivers and
other workers [27,28]. As shown in Table 5, the odds ratio of Mets
was increased with increasing driving time per week. Also odds
ratio of MetS in smoker drivers was increased in a statistically
significant manner in relation to increasing pack-years of smoking.
The odds ratio of the MetS was 1.21(1.09–1.34) for smoking 10
pack-years or less, 2.12(1.78–2.54) for smoking 10.1–20 pack-years
and 3.49(2.80–4.36) in those with smoking more than 20 pack-
years. There is some evidence that smokers are at greater risk than
nonsmokers of becoming MetS [29–30]. Based on Lee et al, the
relative risk of developing MetS in subjects who smoked more than
20 pack-years was 1.9 (95% CI 1.1–3.7) [31].
This study has several limitations. One of which is the cross-
sectional nature of the data, so providing causal inferences of MetS
was impossible. The study included men exclusively. Moreover,
we did not have a control group of general population to quantify
the attributable risk of driving for MetS. We did not examine
dietary habits and daily exercise with objective methods, so we
were not able to study the exact mechanisms of developing MetS
in the study population. Of course, professional driving is
associated with substantial changes in lifestyle habits. Physical
inactivity is common in long distance drivers. In addition, in the
interview with some subjects, we informed the drivers that while
they consumed low daily vegetables and little fruit, their foods
contained high saturated fat, were rich in animal proteins, and
high in glycemic index. The study suggests that MetS has become
a noteworthy health problem among the Iranian long distance
drivers. This might be due to their working condition which has to
be performed in a fix sitting position, job stress, unhealthy diet and
physical inactivity. Educational programs should be established for
promoting healthy lifestyle and also for early detection and
appropriate interventions. Periodically educational courses on
‘‘smoking cessation’’ are suggested. More research is needed to
identify moderators of long-term stressors on MetS in long
distance drivers.
Table 2. Prevalence of the metabolic syndrome and its components according to age groups of study subjects.
Age groups (years) All age groups
Components
of MetS
20–24
N( % )
25–29
N( % )
30–34
N( % )
35–39
N( % )
40–44
N( % )
45–49
N( % )
50–54
N( % )
55–59
N( % )
60–64
N( % )
65–69
N( % )
Crude
prevalence
(%)
Age
standardized
prevalence (%)
Mets 92 (13.5) 440 (17.9) 546 (24.1) 626 (32.6) 554 (34.5) 598 (42.6) 466 (45.7) 253 (46.9) 90 (49.2) 32 (51.6) 30.5 32.4
High Blood pressure 186 (27.4) 666 (27.1) 720 (31.8) 704 (36.6) 668 (41.5) 711 (50.6) 610 (59.9) 383 (71.1) 137 (74.9) 49 (79.0) 39.8 44.6
High triglycerides 200 (29.5) 929 (37.8) 1038 (45.9) 984 (51.2) 849 (52.8) 775 (55.2) 540 (53.0) 254 (47.1) 87 (47.5) 25 (40.3) 46.8 45.5
Low HDL- C 237 (34.9) 880 (35.8) 796 (35.2) 698 (36.3) 515 (32.0) 442 (31.5) 315 (30.9) 161 (29.9) 45 (24.6) 15 (24.2) 33.8 32.7
High
FBG
30 (4.4) 138 (5.6) 204 (9.0) 279 (14.5) 291 (18.1) 391 (27.8) 273 (26.8) 165 (30.6) 64 (35.0) 21 (33.9) 15.3 17.5
Increased Waist
circumference
162 (23.9) 821 (33.4) 1038 (45.9) 1033 (53.7) 950 (59.1) 886 (63.1) 686 (67.3) 376 (69.8) 125 (68.3) 47 (75.8) 50.5 51.9
doi:10.1371/journal.pone.0031790.t002
Table 3. Number of criteria indicating MetS in study subjects according to age groups.
Age group (Years) All age groups
Number of
criteria 20–24 25–29 30–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69
Crude
prevalence
Age-adjusted
prevalence (%)
0 N (%) 220 (32.4) 694 (28.2) 454 (20.1) 296 (15.4) 205 (12.7) 156 (11.1) 96 (9.4) 33 (6.1) 6 (3.3) 3 (4.8) 2163 (17.8) 16.8
1 N (%) 224 (33.0) 717 (29.2) 619 (27.4) 466 (24.2) 368 (22.9) 251 (17.9) 161 (15.8) 87 (16.1) 37 (20.2) 12 (19.4) 2942 (24.2) 23.9
2 N (%) 132 (19.4) 561 (22.8) 595 (26.3) 488 (25.4) 443 (27.5) 356 (25.3) 262 (25.7) 154 (28.6) 41 (22.4) 14 (22.6) 3046 (25.1) 24.5
3 N (%) 85 (12.5) 353 (14.4) 420 (18.6) 458 (23.8) 382 (23.8) 374 (26.6) 296 (29.0) 143 (26.5) 63 (34.4) 16 (25.8) 2590 (21.3) 22.1
4 N (%) 18 (2.7) 124 (5.0) 148 (6.5) 193 (10.0) 178 (11.1) 220 (15.7) 169 (16.6) 95 (17.6) 30 (16.4) 16 (25.8) 1191 (9.8) 10.9
5 N (%) 0 (.0) 8 (.3) 27 (1.2) 22 (1.1) 32 (2.0) 48 (3.4) 35 (3.4) 27 (5.0) 6 (3.3) 1 (1.6) 206 (1.7) 1.9
doi:10.1371/journal.pone.0031790.t003
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During a health survey on long distance professional drivers to
assess their occupational health state, drivers residing in West
Azerbaijan province were screened for the presence of MetS.
Randomly selected long distance professional divers aged 20–69
years were included in the study, using stratified sampling from
December 2007 to March 2010. The main ethnic groups living in
the West Azerbaijan province are Azeries (Turks) and Kurds.
Those drivers who were working for less than one year and those
who rejected to participate in the study were excluded. All
participants signed written constant forms approved by the ethical
committee of Urmia University of Medical Sciences.
Medical history and clinical examination
According to a national protocol, each participant was
interviewed by trained physicians and completed a questionnaire
containing information on demographics, anthropometric profile,
individual characteristics associated with the past medical history,
and biochemical parameters. Waist circumference was measured
at the level of the umbilicus in the standing position of subjects.
After five minutes rest, the subjects’ blood pressure was measured
by Iranian Institute of Standards and Industrial Researches, using
a standard mercury sphygmomanometer with a suitable cuff
calibrated. Two consecutive diastolic and systolic blood pressures
were recorded on the right arm. If the difference of the two-
measurements exceeded 5% (i.e., .5 mmHg out of the
100 mmHg), blood pressure was measured for a third time. There
were at least 30 seconds interval between these separate
measurements, and the average of the two closest readings was
considered for analyses.
Serum lipid and glucose analysis
Baseline blood samples were drawn into vacutainer tubes
between 7:00 to 9:00 a.m. All the participants had fasted $10 h.
Fasting plasma glucose and lipids were quantified at the time of
specimen collection in the central laboratory of UMSU, a
reference laboratory that has served Urmia residents for decades.
Blood glucose and lipids, including triglycerides, and high-density
lipoproteins were analyzed using a BT-3000 auto-analyzer
(Biotecnica, Rome, Italy). The HDL cholesterol and triglyceride
were assayed using enzymatic tests with commercially available
kits (Pars Azmoon Inc., Iran). Plasma glucose was measured by the
glucose-peroxidase colorimetric enzymatic method with a sensi-
tivity of 5 mg/dL and intra-assay coefficients of variation (CV)
1.7% in lower limit and 1.4% in upper limit concentrations. Inter-
assay CV for the assay was 1.1% in lower limit and 0.6% in upper
limit concentrations. Fasting plasma glucose (FPG) more than
100 mg/dl was defined abnormal in this study. All samples were
analyzed when daily internal quality control met the acceptable
criteria.
Definition of MetS
The IDF in 2005, has proposed a ‘‘consensus’’ definition of
MetS in which waist circumference cut-off thresholds have been
made based on ethnicity [32]. All subjects were screened for MetS
using IDF criteria that included the presence of central adiposity
on the basis of waist circumference $94 cm plus two or more of
the following four factors: 1) elevated concentration of triglycer-
ides(TG): $150 mg/dl (1.7 mmol/l); 2) reduced concentration of
high-density lipoprotein cholesterol (HDL-C): ,40 mg/dl (1.03
mmol/l); 3) elevated blood pressure: systolic blood pressure(SBP)
Table 4. The association of BMI with prevalence of MetS*.
MetS
BMI(kg/m
2)
Present
N( % )
Absent
N( % )
Sum
N( % )
#20.0 10 (2.2) 455 (97.8) 465 (100.0)
20.1–25.0 250 (6.2) 3804 (93.8) 4054 (100.0)
25.1–30.0 1787 (35.5) 3240 (64.5) 5027 (100.0)
30.1–35.0 1412 (62.8) 835 (37.2) 2247 (100.0)
.35.1 238 (69.0) 107 (31.0) 345 (100.0)
Total 3697 (30.5) 8441 (69.5) 12138 (100.0)
*P,0.001.
doi:10.1371/journal.pone.0031790.t004
Table 5. Odds Ratio (OR) and 95% Confidence Interval (CI) for MetS with some risk factors by using logistic regression.
Variable B S.E. P- value OR (95% CI)
Weekly driving duration Less than 45 hours ,0.001
60 or more than 60 hours 0.420 0.052 ,0.001 1.5(1.4–1.7)
Driving experiences less than 10 years 0.002
20 or more than 20 years 0.249 0.075 0.001 1.3(1.1–1.5)
Smoking Non Smoking ,0.001
10 pack-years or less 0.188 0.054 0.001 1.2(1.1–1.3)
10.1–20 pack-years 0.753 0.091 ,0.001 2.1(1.8–2.5)
More than 20 pack-years 1.251 0.113 ,0.001 3.5(2.8–4.4)
Age Less than 25 years ,0.001
35–49 years 0.296 0.064 ,0.001 1.3(1.2–1.5)
50 or more than 50 years 0.579 0.083 ,0.001 1.8 (1.5–2.1)
BMI 25 or less than 25 kg/m
2 ,0.001
25.01–30 kg/m
2 1.915 0.063 ,0.001 6.8 (6.0–7.7)
More than 30 kg/m
2 2.242 0.054 ,0.001 9.4 (8.48–10.5)
doi:10.1371/journal.pone.0031790.t005
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4) elevated fasting plasma glucose(FBG) concentration $100 mg/
dl (5.6 mmol/l). Normal weight was defined as BMI ,25 kg/m2;
overweight was defined as BMI $25 kg/m2; and obesity was
defined as BMI $30 kg/m2.
Statistical analysis
Data are presented as frequencies, and percentages. STATA 8
software was used for data analysis. Continuous variables are
expressed as mean 6 standard deviation (SD). Pearson’s chi-
square test was applied to test the association of categorical
variables, and ANOVA was used to compare the mean number of
components of MetS among drivers of different age groups. A test
for trend was used to compare the prevalence of MetS among age
groups. Logistic regression analyses were used to explore the
contribution of baseline variables as independent variables of
MetS including: age, BMI, smoking habit, driving experiences and
weekly duration of driving as a working in fixed sitting position. To
be able to compare our results with that of other studies, the
findings were standardized with the World Health Organization
world standard population [33].
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